Biomarin Pharmaceutical BMRN
NASDAQ BMRN
$60.03 +0.16 (+0.27%)
At close: Sep 30, 2026 · 4:00 PM EDT

Biomarin Pharmaceutical (BMRN) Capital Expenditures (2009 - 2026)

Updated

Biomarin Pharmaceutical's Capital Expenditures came in at $28.82 million for Q2 2026, up 68.5% from $17.1 million a year earlier and up 37.7% from the prior quarter.

Analysis

Biomarin Pharmaceutical (BMRN) Capital Expenditures (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Biomarin Pharmaceutical reported Capital Expenditures of $118.91 million, up 65.5% year-over-year; for FY2025, it came in at $103.04 million, up 20.6% from FY2024.

  • Capital Expenditures carries a five-year compound annual growth rate of -2.1% (FY2020 to FY2025).
  • Going back by year, Capital Expenditures was $85.42 million in FY2024 (-11.7%), $96.69 million in FY2023 (-20.1%), $120.96 million in FY2022 (+26.6%) and $95.58 million in FY2021 (-16.4%).
  • The five-year range for quarterly Capital Expenditures is $16.77 million (Q1 2025) to $40.72 million (Q4 2025).
  • Year-over-year, Capital Expenditures has increased for four consecutive quarters, with growth averaging 19.1% over the last eight quarters.
  • The fastest year-over-year change in Capital Expenditures over five years came in Q4 2025 (growth of 108.5%), and the weakest in Q1 2025 (a decline of 35.8%).
  • Business Quant data shows BMRN's Capital Expenditures at $20.92 million (Q1 2026), $40.72 million (Q4 2025) and $28.45 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.32 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 322.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -763.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 112.20 Mn
10 Biomarin Pharmaceutical 11.59 Bn 5.45 Bn 786.91 Mn 28.82 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28.82 Mn
Mar 31, 2026 20.92 Mn
Dec 31, 2025 40.72 Mn
Sep 30, 2025 28.45 Mn
Jun 30, 2025 17.10 Mn
Mar 31, 2025 16.77 Mn
Dec 31, 2024 19.53 Mn
Sep 30, 2024 18.46 Mn
Jun 30, 2024 21.33 Mn
Mar 31, 2024 26.10 Mn
Dec 31, 2023 28.92 Mn
Sep 30, 2023 21.74 Mn
Jun 30, 2023 21.58 Mn
Mar 31, 2023 24.46 Mn
Dec 31, 2022 35.69 Mn
Sep 30, 2022 29.30 Mn
Jun 30, 2022 27.15 Mn
Mar 31, 2022 28.82 Mn
Dec 31, 2021 28.74 Mn
Sep 30, 2021 18.73 Mn
API Access

Biomarin Pharmaceutical Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BMRN&period=max&api_key=YOUR_API_KEY